Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins (original) (raw)

References

1. Sanders, C. C., Sanders, W. E.: Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases. Antimicrobial Agents and Chemotherapy 1979, 15: 792–797.
   PubMed Google Scholar
2. Perkins, R. L., Fass, R. J., Warner, J. F., Prior, R. B., File, T. M., Tight, R. R., Gardner, W. G., Ruiz, D. E., Slama, T. G.: Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients. Journal of Infectious Diseases 1978, 137, Supplement: 110–118.
   Google Scholar
3. Winston, D. J., Busuttil, R. W., Kurtz, T. O., Young, L. S.: Moxalactam therapy for bacterial infections. Archives of Internal Medicine 1981, 141: 1607–1612.
   PubMed Google Scholar
4. Bittner, M. J., Dworzack, D. L., Preheim, L. C., Tofte, R. W., Crosstey, K. B.: Ceftriaxone therapy of serious bacterial infections in adults. Antimicrobial Agents and Chemotherapy 1983, 23: 261–266.
   PubMed Google Scholar
5. Goering, R. V., Ruff, E. A.: Comparative analysis of conjugative plasmids mediating gentamicin resistance in_Staphylococcus aureus_. Antimicrobial Agents and Chemotherapy 1983, 24: 450–452.
   PubMed Google Scholar
6. Gootz, T. D., Sanders, C. C., Goering, R. V.: Resistance to cefamandole: derepression of beta-lactamases of cefoxitin and mutation in_Enterobacter cloacae_. Journal of Infectious Diseases 1982, 146: 34–42.
   PubMed Google Scholar
7. Gates, M. L., Sanders, C. C., Goering, R. V., Sanders, W. E.: Evidence of multiple forms of type I chromosomal beta-lactamase in_Pseudomonas aeruginosa_. Antimicrobial Agents and Chemotherapy 1986, 30: 453–457.
   PubMed Google Scholar
8. Werner, V., Sanders, C. C., Sanders, W. E., Goering, R. V.: Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of_Enterobacter cloacae_. Antimicrobial Agents and Chemotherapy 1985, 27: 455–459.
   PubMed Google Scholar
9. Nichols, L., Gudmundsson, S., Maki, D. G.: Experience with cefsulodin therapy for lower respiratory tract infections caused by_Pseudomonas aeruginosa_ in adults without cystic fibrosis or granulocytopenia. Reviews of Infectious Diseases 1984, 6, Supplement 3: S711-S720.
   PubMed Google Scholar
10. Richmond, M. H., Sykes, R. B.: The beta-lactamases of gram-negative bacteria and their possible physiologic role. Advances in Microbiology and Physiology 1983, 9: 31–88.
    Google Scholar
11. Findell, C. M., Sherris, J. C.: Susceptibility_of Enterobacter_ to cefamandole: evidence for a high mutation rate to resistance. Antimicrobial Agents and Chemotherapy 1976, 9: 970–974.
    PubMed Google Scholar
12. Yotsuji, A., Minami, S., Araki, Y., Inoue, M., Mitsuhashi, S.: Inducer activity of beta-lactam antibiotics for the beta-lactamases of_Proteus rettgeri_ and_Proteus vulgaris_. Journal of Antibiotics 1982, 35: 1590–1593.
    PubMed Google Scholar
13. Preheim, L. C., Penn, R. G., Sanders, C. C., Goering, R. V., Giger, D. K.: Emergence of resistance during moxalactam therapy of_Pseudomonas aeruginosa_ infections. Antimicrobial Agents and Chemotherapy 1983, 22: 1037–1041.
    Google Scholar
14. Godfrey, A. J., Bryan, L. E., Rabin, H. R.: Beta-lactamresistant_Pseudomonas aeruginosa_ with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrobial Agents and Chemotherapy 1981, 19: 705–711.
    PubMed Google Scholar
15. Mirelman, D., Nuchamowitz, Y., Rubenstein, E.: Insensitivity of peptidoglycan biosynthetic reactions to beta-lactam antibiotics in a clinical isolate of_Pseudomonas aeruginosa_. Antimicrobial Agents and Chemotherapy 1981, 19: 687–695.
    PubMed Google Scholar
16. Scully, B. E., Neu, H. C.: The use of ceftizoxime in the treatment of critically ill patients infected with multiply antibiotic resistant bacteria. Journal of Antimicrobial Chemotherapy 1982, 10, Supplement C: 141–150.
    Google Scholar
17. Jarlier, V., Philippon, A., Nicholas, M. H., Bismuth, R., Paul, G., Fusciardi, J.:Enterobacter cloacae: emergence in vivo d'un variant resistant aux nouvelles beta-lactamines lord d'un traitment par lamoxactam-gentamicine. Pathologie Biologie 1984, 32: 399–403.
    PubMed Google Scholar

Download references